There have been two pilot studies discussing submission to FDA through R Shiny. With such application, an efficient and interactive review can be conducted from regulatory side. While most of the application focuses on using R Shiny apps within organization for internal review of compound, R Shiny such as {teal} can be implemented for DMC activities. Interactive dashboard using R to perform analysis, which can be inclusive to study-specified analysis and endpoint, such as {rtables}, {tern}, and {teal}. Moreover, such approach can provide downloadable/portable files for further reference. In this session, we will discuss feasibility of such application into DMC activity.